Monitor for insider selling activity as the registration becomes effective. The stock may face downward pressure from the overhang of 13.8 million shares available for resale. Watch for warrant exercise activity, which could provide additional capital but further dilute shareholders.
Price Chart
Executive Summary
ProMIS Neurosciences filed an S-3 shelf registration to register 13,830,592 common shares for resale by selling securityholders, including shares issued in a $75.5 million private placement on January 29, 2026. The company will not receive proceeds from the resale but will receive funds if warrants are exercised. This filing signals potential future share issuance and significant insider selling, which could pressure the stock price.
Key Financial Metrics
Key Facts
- S-3 shelf registration filed for resale of 13,830,592 common shares by selling securityholders
- Shares include 6.8 million common shares, 6.9 million from warrant exercises, and 100,000 from pre-funded warrants issued in a $75.5 million private placement
- ProMIS will not receive proceeds from resale but will receive funds if warrants are exercised at $14.40 (common warrants) or $0.0001 (pre-funded warrants)
- Major institutional holders like Janus Henderson, Wellington, and Deep Track are among the selling securityholders
- Company has $15.4 million in cash as of September 30, 2025, with a history of significant operating losses
Financial Impact
Potential dilution of up to 154% of current shares outstanding (8.97 million) if all warrants are exercised, with maximum offering price of $253 million based on $18.32/share
Risk Factors
- Significant insider selling could depress the stock price
- Potential for substantial dilution if all warrants are exercised
- Company has a history of operating losses and may need additional financing
Market Snapshot
Investment Themes
Documents Analyzed
This report is based on 8 SEC documents filed with EDGAR.
| Document | Accession Number |
|---|---|
| S-3 Filing (Primary) | 0001104659-26-030939 |
| Document: pmn-20260318xex5d4.htm | 0001104659-26-030939 |
| Document: pmn-20260318xexfees.htm | 0001104659-26-030939 |
| Document: pmn-20260318xex23d1.htm | 0001104659-26-030939 |
| Document: 0001104659-26-030939-index-headers.html | 0001104659-26-030939 |
| Document: 0001104659-26-030939-index.html | 0001104659-26-030939 |
| Document: 0001104659-26-030939.txt | 0001104659-26-030939 |
| CONTEXT: 10-Q (2025-11-12) | 0001104659-25-109719 |
Filters
| Type | Now | ||||
|---|---|---|---|---|---|
Oct 6, 2026 20d ago | 3 | $9.12 $9.15 | ▲ +0.33% | ▲ +0.75% | $9.18 (+0.67%) |
Oct 6, 2026 21d ago | Press Release | $9.21 $9.12 | ▼ −0.98% | ▼ −0.74% | $9.18 (−0.32%) |
Sep 1, 2026 8w ago | Press Release | $13.35 $13.98 | ▲ +4.68% | ▲ +4.24% | $9.18 (−31.23%) |
Jul 14, 2026 15w ago | Press Release | $13.66 $14.01 | ▲ +2.53% | ▲ +2.13% | $9.18 (−32.79%) |
May 28, 2026 21w ago | Press Release | $10.87 $10.81 | ▼ −0.55% | ▼ −0.79% | $9.18 (−15.54%) |
May 12, 2026 24w ago | 8-K | $10.49 $10.57 | ▲ +0.76% | ▲ +0.19% | $9.18 (−12.48%) |
Apr 3, 2026 29w ago | EFFECT | $10.96 $10.88 | ▲ +0.73% | ▲ +0.79% | $9.18 (+16.23%) |
Mar 25, 2026 30w ago | S-3 | $15.13 $14.74 | ▲ +2.58% | ▲ +0.90% | $9.18 (+39.32%) |
Mar 18, 2026 31w ago | S-3 | $18.21 $17.60 | ▲ +3.35% | ▲ +1.61% | $9.18 (+49.58%) |
US Market Status
Subscribe to SecBot
Get Real-Time SEC Filing Intelligence
Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.
Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers